Home - Systemic Juvenile Idiopathic Arthritis Foundation

Our simple and urgent focus is finding a cure for Systemic JIA also known as Still's Disease.

NextGen Therapies in SJIA, Still's & MAS Conference. From Feb 16th-18th, 2022. Virtual Event.

Learn More

The Systemic JIA Foundation is a non-profit dedicated to accelerating research & treatment for Systemic JIA (Systemic Juvenile Idiopathic Arthritis), also known as Still’s Disease and associated complications such as Macrophage Activation Syndrome.

Recent Events

In our mission to find a cure, we bring researchers, patients, clinicians, pharma and regulators together at our events.

SJIA Family Conference 2019

SJIA Family Conference 2019

Organized by the Systemic JIA Foundation & Rheumatology Department, Cincinnati Children’s Hospital... read more

NextGen Therapies for SJIA & MAS – 2019

NextGen Therapies for SJIA & MAS – 2019

The goal of this meeting to accelerate search for therapies for refractory Systemic JIA, recurrent MAS and associated lung disease. We will be bringing together experts who research these areas, clinicians... read more

SJIA Family Education Day at Cincinnati Children's

SJIA Family Education Day at Cincinnati Children's

Organized jointly by the SJIA Foundation and Cincinnati Children's Rheumatology Department...read more

Our Twitter Feed

Our Facebook Page

Timeline photosOn 28 February 2023, the rare disease community will come together to spread hope and solidarity in a ✨ Global Chain of Lights ✨You can #LightUpForRare by:🔦 Illuminating a monument in your city!🔦 Lighting up your home using our filters and in the Rare Disease Day colours!🔦 Posting your pictures with the hashtag #LightUpForRare on social media!👉 Learn how to illuminate a building: cutt.ly/jYNFp5X👉 Learn how to light up your home: cutt.ly/UYNFkKVTell us in the comments how you will #LightUpForRare!...#RareDiseaseDay #RareDiseases #ShareYourColours #LightUpForRare #Awareness #Support #Worldwide #Equity #Community ... See MoreSee Less
View on Facebook
Please join this free talk by an HLH expert if you are interested in SJIA and MAS. MAS shares a lot in common with HLH. Additionally many new MAS and SJIA treatments have been first used in HLH (e.g., ruxolitinib, emapalumab and bone marrow transplantation). Additionally Michael Jordan is one of the top experts on HLH and a great speaker. ... See MoreSee Less
View on Facebook

Keep in touch. Sign up for our email updates.